-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Venadaparib in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Venadaparib in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venadaparib in Breast Cancer Drug Details: IDX-1197 (NOV1401) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Venadaparib in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Venadaparib in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venadaparib in Gastric Cancer Drug Details: IDX-1197 (NOV1401) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Venadaparib in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Venadaparib in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venadaparib in Pancreatic Cancer Drug Details: IDX-1197 (NOV1401) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Venadaparib in Gastroesophageal (GE) Junction Carcinomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Venadaparib in Gastroesophageal (GE) Junction Carcinomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venadaparib in Gastroesophageal (GE) Junction Carcinomas Drug Details: IDX-1197 (NOV1401)...
-
Thematic Analysis
NewGlobal Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...
-
Product Insights
Optical Coherence Tomography (OCT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Optical Coherence Tomography (OCT) Pipeline Market Report Overview Optical Coherence Tomography (OCT) equipment allows for the imaging and measurement of retinal thickness. The Optical Coherence Tomography pipeline market research report provides comprehensive information about the OCT pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories ·       The US ·       China ·       Europe ·       Global ·       Japan Key Regulatory Paths ·       510(k) ·       NMPA...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Venadaparib in Gastroesophageal (GE) Junction Carcinomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Venadaparib in Gastroesophageal (GE) Junction Carcinomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venadaparib in Gastroesophageal (GE) Junction Carcinomas Drug Details: IDX-1197...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Venadaparib in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Venadaparib in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venadaparib in Ovarian Cancer Drug Details: IDX-1197 (NOV1401) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Venadaparib in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Venadaparib in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venadaparib in Solid Tumor Drug Details: IDX-1197 (NOV1401) is under development...
-
Product Insights
Ophthalmic Diagnostic Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ophthalmic Diagnostic Equipment Pipeline Market Report Overview Ophthalmic diagnostic equipment helps in examining the eye for study purposes as well as for the treatment of different pathologies of the eye. The Ophthalmic Diagnostic Equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the...